版权说明 操作指南
首页 > 成果 > 详情

Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals

认领
导出
下载 Link by 万方学术期刊
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Zhang, Jian;Wu, Qian;Liu, Ziyan;Wang, Qijie;Wu, Jiajing;...
通讯作者:
Liu, Wenpei;Qu, Xiaowang;Wang, Youchun;Li, Yi-Ping
作者机构:
[Wu, Zhijian; Zhang, Jian; Liu, Ziyan; Jin, Kun; Huang, Renbin; Li, Guicheng; Wu, Qian; Qu, Xiaowang; Niu, Ling; Lei, Dongzhu; Hu, Yabin; Lin, Yingbiao; Guo, Wangyuan; Luo, Dixian; Liu, Wenpei] Univ South China, Peoples Hosp Chenzhou 1, Translat Med Inst, Chenzhou, Peoples R China.
[Xie, Ting; Peng, Danhong; Huang, Mincheng; He, Shuangyan; Xie, Xiangping; Zeng, Ting; Wang, Qijie] Cent Hosp Shaoyang, Shaoyang, Peoples R China.
[Huang, Weijin; Wu, Jiajing; Wang, Youchun] Natl Inst Food & Drug Control, Minist Hlth Res Qual & Standardizat Biotech Prod, Key Lab Biol Prod Qual Res & Evaluat, Natl Med Prod Adm,Key Lab, Beijing, Peoples R China.
[Wu, Jiajing] Wuhan Inst Biol Prod, Wuhan, Peoples R China.
[Bai, Tingting; Liu, Wenpei] Southern Med Univ, Sch Clin Med 1, Guangzhou, Peoples R China.
通讯机构:
[Liu, WP; Qu, XW] U
[Wang, Youchun] N
[Liu, Wenpei; Li, Yi-Ping; Qu, Xiaowang] S
Univ South China, Peoples Hosp Chenzhou 1, Translat Med Inst, Chenzhou, Peoples R China.
Natl Inst Food & Drug Control, Minist Hlth Res Qual & Standardizat Biotech Prod, Key Lab Biol Prod Qual Res & Evaluat, Natl Med Prod Adm,Key Lab, Beijing, Peoples R China.
语种:
英文
期刊:
NATURE MICROBIOLOGY
ISSN:
2058-5276
年:
2021
卷:
6
期:
1
页码:
51-58
基金类别:
We thank all of the participants. This work was supported by the COVID-19 Emergency Special Program of Hunan Province (no. 2020SK3052, to W. Liu), Key Research and Development Project of Chenzhou City, Hunan Province (no. ZDYF2020010 and ZDYF2020007) and by the SC1-PHE-CORONAVIRUS-2020: Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic’ from the European Commission (CORONADX, no. 101003562, to Y.-P.L.).
机构署名:
本校为第一且通讯机构
院系归属:
医学院
摘要:
Coronavirus disease 2019 (COVID-19) is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)(1-3) and individuals with COVID-19 have symptoms that can be asymptomatic, mild, moderate or severe(4,5). In the early phase of infection, T- and B-cell counts are substantially decreased(6,7); however, IgM(8-11) and IgG(12-14) are detectable within 14 d after symptom onset. In COVID-19-convalescent individuals, spike-specific neutralizing antibodies are variable(3,15,16). No specific drug or vaccine is available for COVID-19 at the time of writing; however, patients ben...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com